KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $64.1 million.

  • BeOne Medicines' Other Non-Current Liabilities rose 2667.3% to $64.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 million, marking a year-over-year increase of 2667.3%. This contributed to the annual value of $66.7 million for FY2024, which is 3134.23% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Other Non-Current Liabilities is $64.1 million, which was up 2667.3% from $63.1 million recorded in Q2 2025.
  • BeOne Medicines' Other Non-Current Liabilities' 5-year high stood at $180.5 million during Q4 2022, with a 5-year trough of $42.0 million in Q3 2023.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $51.8 million (2022), whereas its average is $59.9 million.
  • In the last 5 years, BeOne Medicines' Other Non-Current Liabilities skyrocketed by 23276.54% in 2022 and then tumbled by 7184.6% in 2023.
  • Over the past 5 years, BeOne Medicines' Other Non-Current Liabilities (Quarter) stood at $54.2 million in 2021, then soared by 232.77% to $180.5 million in 2022, then plummeted by 71.85% to $50.8 million in 2023, then skyrocketed by 31.34% to $66.7 million in 2024, then decreased by 4.01% to $64.1 million in 2025.
  • Its Other Non-Current Liabilities stands at $64.1 million for Q3 2025, versus $63.1 million for Q2 2025 and $65.6 million for Q1 2025.